The Russian-made Sputnik V coronavirus vaccine has shown the best result in preventing Covid-19 mortality, compared to the other leading formulas, according to a comprehensive study based on Hungary’s mass-vaccination drive.

The comparative analysis of the performance of different jabs used in the central European country was unveiled, on Thursday, by the Russian Direct Investment Fund (RDIF), the sovereign wealth fund that bankrolled the jab’s development.

“With 98% efficacy in preventing COVID-related mortality and 85.7% efficacy against coronavirus infection Sputnik V has demonstrated the best results among five vaccines (Sputnik V, Moderna, Pfizer-BioNTech, Sinopharm and AstraZeneca) administered in EU member state Hungary as part of an independent study based on data from 3.7 million people,” the CEO of the RDIF, Kirill Dmitriev, said in a statement on Thursday.

While beating all the competitors in terms of protecting against coronavirus-related mortality, Sputnik V came second in Hungary in preventing the disease itself. The best result, in this category, was delivered by the US-made Moderna shot, which demonstrated 98% efficacy compared to 86% shown by Sputnik V. (RT)